Do all colchicine preparations have the same effectiveness in patients with familial Mediterranean fever?

References

• Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med. 2007;65(9):318–24.
   PubMed Web of Science ®Google Scholar
• Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med. 1972;287(25):1302.
   PubMed Web of Science ®Google Scholar
• Ozkan E, Okur O, Ekmekçi A, Ozcan R, Tag T. A new approach to the treatment of periodic fever. Med Bull İstanbul. 1972;5:44–9.
   Google Scholar
• Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007;119(2):e474–e483.
   PubMed Web of Science ®Google Scholar
• Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Koné-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum. 2011;41(2):265–71.
   PubMed Web of Science ®Google Scholar
• Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit R, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644–51.
   PubMed Web of Science ®Google Scholar
• Kisla Ekinci RM, Balci S, Dogruel D, Altintas DU, Yilmaz M. Canakinumab in children with familial Mediterranean fever: a single-center, retrospective analysis. Paediatr Drugs. 2019;21(5):389–95.
   PubMed Web of Science ®Google Scholar
• Başaran Ö, Uncu N, Çelikel BA, Taktak A, Gür G, Cakar N. Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients. Mod Rheumatol. 2015;25(4):621–4.
   PubMed Web of Science ®Google Scholar
• Cetin P, Sari I, Sozeri B, Cam O, Birlik M, Akkoc N, et al. Efficacy of interleukin-1 targeting treatments in patients with familial Mediterranean fever. Inflammation. 2015;38(1):27–31.
   PubMed Web of Science ®Google Scholar
• Özçakar ZB, Yüksel S, Ekim M, Yalçınkaya F. Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up. Clin Rheumatol. 2012;31(8):1267–71.
   PubMed Web of Science ®Google Scholar
• Turkish Medicines and Medical Devices Agency [Internet]. https://www.titck.gov.tr [last accessed 06 Aug 2019].
   Google Scholar
• Turkish Pharmacists’ Association [Internet]. https://www.teb.org.tr [last accessed 06 Aug 2019].
   Google Scholar
• Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford). 2009;48(4):395–8.
   PubMed Web of Science ®Google Scholar
• Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med. 1974;81(6):792–4.
   PubMed Web of Science ®Google Scholar
• Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum. 1991;34(8):973–7.
   PubMed Web of Science ®Google Scholar
• Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314(16):1001–5.
   PubMed Web of Science ®Google Scholar
• Ozen S, Kone-Paut I, Gül A. Colchicine resistance and intolerance in familial Mediterranean fever: definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017;47(1):115–20.
   PubMed Web of Science ®Google Scholar
• Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine: old and new. Am J Med. 2015;128(5):461–70.
   PubMed Web of Science ®Google Scholar
• Niel E, Scherrmann JM. Colchicine today. Joint Bone Spine. 2006;73(6):672–8.
   PubMed Web of Science ®Google Scholar
• Terkeltaub RA. Colchicine update: 2008. Semin Arthritis Rheum. 2009;38(6):411–9.
   PubMed Web of Science ®Google Scholar
• Hart J, Lewin KJ, Peters RS, Schwabe AD. Effect of long-term colchicine therapy on jejunal mucosa. Digest Dis Sci. 1993;38(11):2017–21.
   PubMed Web of Science ®Google Scholar
• Chappey ON, Niel E, Wautier JL, Hung PP, Dervichian M, Cattan D, et al. Colchicine disposition in human leukocytes after single and multiple oral administration. Clin Pharmacol Ther. 1993;54(4):360–7.
   PubMed Web of Science ®Google Scholar
• Suarez S, Marroum PJ, Hughes M, Biopharmaceutic considerations in drug product design and in vitro drug product performance. In: Shargel L, Yu ABC, editors. Applied Biopharmaceutics and Pharmacokinetics. 7th ed. New York: McGraw Hill Education; 2016. p. 415–67.
   Google Scholar
• Shargel L, Yu ABC, Impact of biopharmaceutics on drug product quality and clinical efficacy. In: Shargel L, Yu ABC, editors. Applied Biopharmaceutics and Pharmacokinetics. 7th ed. New York: McGraw Hill Education; 2016. p. 545–65.
   Google Scholar
• Ferron GM, Rochdi M, Jusko WJ, Scherrmann JM. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses. J Clin Pharmacol. 1996;36(10):874–83.
   PubMed Web of Science ®Google Scholar
• Amanova A, Kendi Celebi Z, Bakar F, Caglayan MG, Keven K. Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. Clin Transplant. 2014;28(10):1177–83.
   PubMed Web of Science ®Google Scholar
• Girre C, Thomas G, Scherrmann JM, Crouzette J, Fournier PE. Model-independent pharmacokinetics of colchicine after oral administration to healthy volunteers. Fundam Clin Pharmacol. 1989;3(5):537–43.
   PubMed Web of Science ®Google Scholar
• Rochdi M, Sabouraud A, Girre C, Venet R, Scherrmann JM. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur J Clin Pharmacol. 1994;46(4):351–4.
   PubMed Web of Science ®Google Scholar
• Angelidis C, Kotsialou Z, Kossyvakis C, Vrettou AR, Zacharoulis A, Kolokathis F, et al. Colchicine pharmacokinetics and mechanism of action. Curr Pharm Des. 2018;24(6):659–63.
   PubMed Web of Science ®Google Scholar
• Emmungil H, İlgen U, Turan S, Yaman S, Küçükşahin O. Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?. Rheumatol Int. 2020;40(1):129–35.
   PubMed Web of Science ®Google Scholar